| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/11/2002 | WO2002053734A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053730A1 Novel potassium channel |
| 07/11/2002 | WO2002053729A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053727A1 Three dimensional structure of human derived apoptotic factor and receptor thereof by x-ray chrystallography and trail deletion mutant protein |
| 07/11/2002 | WO2002053726A2 Protein-protein interactions in adipocyte cells |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |
| 07/11/2002 | WO2002053719A2 Cytoskeleton-associated proteins |
| 07/11/2002 | WO2002053712A2 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | WO2002053709A1 Cartilage marker gene, method for the production and use thereof |
| 07/11/2002 | WO2002053701A2 Epididymal lipocalin gene and uses thereof |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053593A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/11/2002 | WO2002053592A1 Novel polypeptide and dna thereof |
| 07/11/2002 | WO2002053591A1 Mammalian nuclear receptor cofactor cf12 and methods of use |
| 07/11/2002 | WO2002053589A2 Nucleic acid molecules encoding dim interactors and uses therefor |
| 07/11/2002 | WO2002053588A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci |
| 07/11/2002 | WO2002053587A2 Polypeptide inducing hiv-neutralising antibodies |
| 07/11/2002 | WO2002053586A2 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 07/11/2002 | WO2002053585A2 Mammalian nuclear receptor cofactor cf11 and methods of use |
| 07/11/2002 | WO2002053583A2 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | WO2002053580A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | WO2002053191A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 07/11/2002 | WO2002053182A1 Chimeric t helper-b cell peptide vaccine for japanese encephalitis virus |
| 07/11/2002 | WO2002053181A1 Enterohemorragic escherichia coli vaccine |
| 07/11/2002 | WO2002053180A2 Immunizing compositions and methods of use |
| 07/11/2002 | WO2002053016A2 Compounds and methods for the diagnosis and treatment of babesia infection |
| 07/11/2002 | WO2002052931A2 Transgenic mice containing gprc5b-like gene disruptions |
| 07/11/2002 | WO2002036621A8 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 07/11/2002 | WO2002034923A8 Monocotyledon plant cells and plants which synthesise modified starch |
| 07/11/2002 | WO2002034780A3 Hetero-oligomeric compounds derived from the tnf cytokine superfamily and their use |
| 07/11/2002 | WO2002032537A3 Improved method of expanded bed chromatography |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002024057A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/11/2002 | WO2002022843A3 Nucleotide sequences which code for the dep34 gene |
| 07/11/2002 | WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002019965A3 Heat shock response and virus replication |
| 07/11/2002 | WO2002016421A8 Altered ospa of borrelia burgdorferi |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002014346A8 Antimicrobial peptides isolated from fish |
| 07/11/2002 | WO2002012479A3 Zcys9: a member of the cystatin superfamily |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002009646A3 Plant derived antioxidants |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001096375A3 33358, a novel human ankyrin family member and uses thereof |
| 07/11/2002 | WO2001094389A3 Zcys7: a member of the cystatin superfamily |
| 07/11/2002 | WO2001087933A3 Zsig33-like peptides |
| 07/11/2002 | WO2001085930A3 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001079274A3 Tuberculosis antigens and methods of use thereof |
| 07/11/2002 | WO2001078756A3 Agent for postoperative use after the removal of bone tumours |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001066752A3 Reproduction-specific genes |
| 07/11/2002 | WO2001066745A3 Presenilin/crk binding polypeptides (pcbp) and methods of use thereof |
| 07/11/2002 | WO2001059094A3 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001044512A3 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001044460A3 Methods and compositions for screening for angiogenesis modulating compounds |
| 07/11/2002 | WO2001040476A3 Bacillus thuringiensis toxin active against formicidae (ant) |
| 07/11/2002 | WO2001040267A3 Proteoglycans and pharmaceutical compositions comprising them |
| 07/11/2002 | WO2001036473A3 Human g protein-coupled receptors |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2001032920A3 Agents implicated in endometriosis |
| 07/11/2002 | WO2001031037A3 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | WO2001028540A3 Agent for treating cephalic pain |
| 07/11/2002 | WO2001027632A3 Cellular receptor mutations predicted by multiple-sequence-allignment |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001025273A3 Compositions and methods for wt1 specific immunotherapy |
| 07/11/2002 | WO2001019857A3 Facilitative transporter (ft1 and ft2) from drosophila melanogaster and uses thereof |
| 07/11/2002 | WO2001016323A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001015729A9 Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
| 07/11/2002 | WO2001012816A3 Porcine endovirus gag and env and diagnostic uses thereof |
| 07/11/2002 | WO2001012809A3 Heterodimeric vegf variants used for inhibiting angiogenesis |
| 07/11/2002 | WO2001012651A3 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 07/11/2002 | WO2001012220A9 Non-immunosuppressant hiv tat |
| 07/11/2002 | WO2001011335A9 Antiviral compounds that inhibit viral replication |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001010907A9 Therapeutic polypeptides and methods for using same |
| 07/11/2002 | WO2001010205A9 Methods and materials relating to cd39-like polypeptides |
| 07/11/2002 | WO2001003680A3 Compounds for inhibiting diseases and preparing cells for transplantation |
| 07/11/2002 | WO2000077486A3 Compositions and methods for detecting treponema pallidum |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000067024A9 Cancer treatment with endothelin receptor antagonists |
| 07/11/2002 | WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061747A9 Clasp-2 transmembrane proteins |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |